References
- Baadsgaard O., Traulsen J., Roed-Petersen J., Jakobsen H. B. Optimal concentration of tacalcitol in once-daily treatment of psoriasis. Dermatol. Treat. 1995; 6: 145–1501. Baadsgaard O., Traulsen J., Roed-Petersen J., Jakobsen H. B. Optimal concentration of tacalcitol in once-daily treatment of psoriasis. Dermatol. Treat. 1995; 6: 145–150
- Gerritsen M. J. P., Boezeman J. B. M., van Vlijmen-Willems I. M. J. J., van de Kerkhof P. C. M. The effect of tacalcitol (1,24(OH)2D3) on cutaneous inflammation, epidermal proliferation and keratinization in psoriasis: a placebo-controlled, double-blind study. Br. J. Dermatol 1994; 131: 57–632. Gerritsen M. J. P., Boezeman J. B. M., van Vlijmen-Willems I. M. J. J., van de Kerkhof P. C. M. The effect of tacalcitol (1,24(OH)2D3) on cutaneous inflammation, epidermal proliferation and keratinization in psoriasis: a placebo-controlled, double-blind study. Br. J. Dermatol 1994; 131: 57–63
- van de Kerkhof P. C. M. Biological activity of vitamin D analogues in the skin, with special reference to antipsoriatic mechanisms. Br. J. Dermatol 1995; 132: 675–6823. van de Kerkhof P. C. M. Biological activity of vitamin D analogues in the skin, with special reference to antipsoriatic mechanisms. Br. J. Dermatol 1995; 132: 675–682
- van de Kerkhof P. C. M., Werfel T., Haustein U. R., Luger T., Czarnetzki B. M., Niemann R., Planitz-Stenzel V. Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicentre, placebo-controlled, double-blind study on efficacy and safety. Br. J. Dermatol 1996; 135: 758–7654. van de Kerkhof P. C. M., Werfel T., Haustein U. R., Luger T., Czarnetzki B. M., Niemann R., Planitz-Stenzel V. Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicentre, placebo-controlled, double-blind study on efficacy and safety. Br. J. Dermatol 1996; 135: 758–765
- van de Kerkhof P. C. M., van der Vleuten C. J. M., Gerritsen M. J. P., Glade C. P., Luger T., Werfel T., Kluss B. Long-term efficacy and safety of once daily treatment of chronic plaque psoriasis with tacalcitol ointment. Eur. J. Dermatol 1997; 7: 421–4255. van de Kerkhof P. C. M., van der Vleuten C. J. M., Gerritsen M. J. P., Glade C. P., Luger T., Werfel T., Kluss B. Long-term efficacy and safety of once daily treatment of chronic plaque psoriasis with tacalcitol ointment. Eur. J. Dermatol 1997; 7: 421–425
- Kokelj E., Plozzer C., Guadagnini A. Topical tacalcitol reduces the total UVB dosage in treatment of psoriasis vulgaris. J. Dermatol. Treat. 1996; 7: 265–2666. Kokelj E., Plozzer C., Guadagnini A. Topical tacalcitol reduces the total UVB dosage in treatment of psoriasis vulgaris. J. Dermatol. Treat. 1996; 7: 265–266
- Nishimura M., Hori Y., Nishiyama S., Nakamizo Y. Topical 1a,24(R)-dihydroxyvitamin D., for the treatment of psoriasis. Review of the literature. Eur. J. Dermatol 1993; 3: 255–2617. Nishimura M., Hori Y., Nishiyama S., Nakamizo Y. Topical 1a,24(R)-dihydroxyvitamin D., for the treatment of psoriasis. Review of the literature. Eur. J. Dermatol 1993; 3: 255–261
- Peters D. C., Balfour J. A. Tacalcitol. Drugs 1997; 54: 265–2718. Peters D. C., Balfour J. A. Tacalcitol. Drugs 1997; 54: 265–271
- Scarpa C. Tacalcitol ointment is an efficacious and well tolerated treatment for psoriasis. J. Euro. Acad. Dermatol Venereol 1996; 6: 142–1469. Scarpa C. Tacalcitol ointment is an efficacious and well tolerated treatment for psoriasis. J. Euro. Acad. Dermatol Venereol 1996; 6: 142–146
- Seidenari S., Magni R., Giannelti A. Assessment of the activity of tacalcitol on psoriatic plaques by means of colorimetry and high-frequency ultrasound: a double-blind intrasubject half-side right-left comparison with betamethasone valerate and placebo. Skin Pharmacol 1997; 10: 40–4710. Seidenari S., Magni R., Giannelti A. Assessment of the activity of tacalcitol on psoriatic plaques by means of colorimetry and high-frequency ultrasound: a double-blind intrasubject half-side right-left comparison with betamethasone valerate and placebo. Skin Pharmacol 1997; 10: 40–47
- Veien N. K., Bjerke J. R., Rossmann-Ringdahl I., Jakobsen H. B. Once-daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. A double-blind trial. Br. J. Dermatol 1997; 137: 581–58611. Veien N. K., Bjerke J. R., Rossmann-Ringdahl I., Jakobsen H. B. Once-daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. A double-blind trial. Br. J. Dermatol 1997; 137: 581–586